Brigham and Women's partners with Evidation Health to research impact of digital tools in clinical trials

By Heather Mack
Share

The innovation arm of Brigham and Women’s Hospital has partnered with efficacy-focused digital health company Evidation Health to collaborate on a project measuring the real life impact of digital health solutions on clinical and financial outcomes.

The idea is to combine forces to develop methods of creating direct-to-patient trials of digital health solutions, leveraging the research capabilities of Brigham and Women’s with the digital tools of Evidation. Through the collaboration, Brigham and Women’s investigators can speed up clinical trials using digital health solutions. This builds on the hospital’s burgeoning Innovation Hub, which was launched in 2013 and fosters innovation, collaboration and translation of technology to improve care delivery.

“We're excited to work with Evidation Health to test the impact of digital health solutions on patient outcomes. Research is core to our mission at Brigham and Women’s Hospital and we are committed to evaluating digital health solutions and adopting those that have the most impact and meet our needs,” Lesley Solomon, executive director of Brigham and Women’s iHub said in a statement.

Evidation Health, which recently announced a $3.4 million in financing from B Capital group, developed its Real Life Study Solution to help a variety of organizations, from payers and pharma to vendors and researchers, prove out the efficacy of their programs and trials. The platform facilitates quick, efficient data collection and large-scale analysis, starting by obtaining participant consent and authorization for data collection, then gathering patient-reported outcomes and data from apps, connected devices and medical records to efficiently analyze the impact of whatever digital intervention they are looking at.

“We’re in an exciting time where hundreds of digital health solutions are emerging in the market -- but a big challenge for the healthcare sector is to generate evidence of their impact,” said Evidation Health CEO Deborah Kilpatrick in a statement. “Our partnership with Brigham and Women’s Hospital iHub is driven by this objective of quantifying the impact of 'what works' in the digital era of medicine.”